OXFORD ASSET MANAGEMENT LLP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$309,000
-90.9%
13,009
-86.6%
0.01%
-87.8%
Q1 2019$3,407,000
+121.1%
97,242
+109.7%
0.07%
+85.0%
Q4 2018$1,541,000
+20.1%
46,376
+65.5%
0.04%
+48.1%
Q1 2018$1,283,000
-39.3%
28,015
-46.6%
0.03%
-41.3%
Q4 2017$2,115,000
+123.3%
52,461
+120.8%
0.05%
+155.6%
Q3 2017$947,000
-55.7%
23,758
-65.2%
0.02%
-65.4%
Q1 2017$2,137,000
+170.8%
68,285
+118.6%
0.05%
+85.7%
Q4 2016$789,000
-75.4%
31,244
-75.9%
0.03%
-71.7%
Q3 2016$3,211,000
-43.4%
129,825
-53.4%
0.10%
-47.1%
Q2 2016$5,676,000
+8.9%
278,668
-18.4%
0.19%
+25.5%
Q1 2016$5,210,000
-2.6%
341,626
-12.6%
0.15%
+18.3%
Q4 2015$5,351,000
+35.7%
390,994
+39.2%
0.13%
+1.6%
Q3 2015$3,942,000
-67.4%
280,966
-60.5%
0.12%
-62.1%
Q2 2015$12,075,000
+1269.0%
711,129
+875.0%
0.33%
+1386.4%
Q1 2015$882,00072,9390.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders